INCB-099318

N/A

Report date: 2024/08/02 20:01:06
NME

Base Information

Drug NameINCB-099318
Drug Alias NameINCB-099318INCB-99318
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProgrammed death-ligand 1 blockers
TargetsProgrammed death-ligand 1
Therapy Area/IndicationsSolid tumoursMicrosatellite instability-high cancerPenile Neoplasms +[17] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesSweden +[7] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIncyte Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIncyte Corp
Active IndicationsN/A
Inactive IndicationsSolid tumoursMicrosatellite instability-high cancerPenile Neoplasms +[17] 

Other Information

ATC CodeN/A
Related LinksN/A